Minimally invasive surgery for clinical T4 non-small-cell lung cancer: national trends and outcomes.
Jorge Humberto Rodriguez QuinteroMostafa M ElbahrawyAnne Michelle MontalRajika JindaniMarc VimolratanaMohamed K KamelBrendon M StilesNeel P ChudgarPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2024)
Nationally, the use of minimally invasive approaches for patients with cT4N0-1M0 NSCLC has increased substantially. In these patients, MIS is safe and does not compromise perioperative outcomes or survival.
Keyphrases
- minimally invasive
- end stage renal disease
- ejection fraction
- small cell lung cancer
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- patients undergoing
- magnetic resonance imaging
- cardiac surgery
- quality improvement
- acute kidney injury
- metabolic syndrome
- advanced non small cell lung cancer
- magnetic resonance
- adipose tissue
- contrast enhanced
- insulin resistance
- positron emission tomography
- robot assisted
- tyrosine kinase